Las Vegas, NV -- (SBWIRE) -- 12/30/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more. EquityObserver.com issues a special report on the following stocks:Rubicon Minerals Corp. (USA)(NYSEMKT:RBY),Athersys, Inc.(NASDAQ: ATHX),China Ming Yang Wind Power Group Ltd(NYSE:MY),BG Medicine, Inc.(NASDAQ:BGMD)
Rubicon Minerals Corp. (USA)(NYSEMKT:RBY)managed to keep its gain at 4.00% on above-normal volume of 1.29Mshares. The stock settled at $0.862, after floating in a range of $0.75 - 0.87. Its latest price has reached market capitalization of $248.81M. Its 52-week range has been $0.65 - 2.69. Rubicon Minerals Corporation (Rubicon) is a mineral exploration company engaged in the acquisition, exploration and development of gold and base-metal exploration properties both through Company funded and partner-funded exploration. The Company is also involved in the investment in other mineral exploration and resource companies.
How Should Investors Trade RBY Now?Don’t Miss out a Special Trend Analysis
Athersys, Inc.(NASDAQ:ATHX)trading on a volume of 1.23Mshares, higher than its standard daily volume. Shares have been closed at $2.43Over the last twelve months, the stock has gained120.91% and faced a worst price of $1.06.Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product.
Is ATHX a Solid Investment at These Levels?Read This Report for Details
China Ming Yang Wind Power Group Ltd(NYSE:MY)is up at $2.32 on above- normal volume of 1.22Mshares during the last trading day. The stock has its 12-month range $1.13 - 3.52. Its Intraday range is $2.15 - 2.33.China Ming Yang Wind Power Group Limited is a wind turbine manufacturer in China, focusing on designing, manufacturing.
How Should Investors Trade MY Now?Don’t Miss out a Special Trend Analysis
In the last trading day, BG Medicine, Inc.(NASDAQ:BGMD)is on low volume, trading at a volume of versus its average daily volume ratio 1.21M/2.21M shares. At $0.980, the stock has attained market capitalization of 27.36M.BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE.
Will Investors Buy BGMD After Reading This News?Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)